These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32402055)
1. Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Performance, Turnaround Time, and Cost. Tafess K; Ng TTL; Lao HY; Leung KSS; Tam KKG; Rajwani R; Tam STY; Ho LPK; Chu CMK; Gonzalez D; Sayada C; Ma OCK; Nega BH; Ameni G; Yam WC; Siu GKH Clin Chem; 2020 Jun; 66(6):809-820. PubMed ID: 32402055 [TBL] [Abstract][Full Text] [Related]
2. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. Colman RE; Mace A; Seifert M; Hetzel J; Mshaiel H; Suresh A; Lemmer D; Engelthaler DM; Catanzaro DG; Young AG; Denkinger CM; Rodwell TC PLoS Med; 2019 Apr; 16(4):e1002794. PubMed ID: 31039166 [TBL] [Abstract][Full Text] [Related]
3. Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples. Cabibbe AM; Spitaleri A; Battaglia S; Colman RE; Suresh A; Uplekar S; Rodwell TC; Cirillo DM J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727827 [TBL] [Abstract][Full Text] [Related]
4. Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis. Chan WS; Au CH; Chung Y; Leung HCM; Ho DN; Wong EYL; Lam TW; Chan TL; Ma ESK; Tang BSF BMC Res Notes; 2020 Sep; 13(1):444. PubMed ID: 32948225 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes. Mariner-Llicer C; Goig GA; Zaragoza-Infante L; Torres-Puente M; Villamayor L; Navarro D; Borras R; Chiner-Oms Á; Comas I Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34919513 [TBL] [Abstract][Full Text] [Related]
6. Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples. Votintseva AA; Bradley P; Pankhurst L; Del Ojo Elias C; Loose M; Nilgiriwala K; Chatterjee A; Smith EG; Sanderson N; Walker TM; Morgan MR; Wyllie DH; Walker AS; Peto TEA; Crook DW; Iqbal Z J Clin Microbiol; 2017 May; 55(5):1285-1298. PubMed ID: 28275074 [TBL] [Abstract][Full Text] [Related]
7. The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs. Phelan J; O'Sullivan DM; Machado D; Ramos J; Whale AS; O'Grady J; Dheda K; Campino S; McNerney R; Viveiros M; Huggett JF; Clark TG Genome Med; 2016 Dec; 8(1):132. PubMed ID: 28003022 [TBL] [Abstract][Full Text] [Related]
8. ECNano: A cost-effective workflow for target enrichment sequencing and accurate variant calling on 4800 clinically significant genes using a single MinION flowcell. Leung AW; Leung HC; Wong CL; Zheng ZX; Lui WW; Luk HM; Lo IF; Luo R; Lam TW BMC Med Genomics; 2022 Mar; 15(1):43. PubMed ID: 35246132 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Hall MB; Rabodoarivelo MS; Koch A; Dippenaar A; George S; Grobbelaar M; Warren R; Walker TM; Cox H; Gagneux S; Crook D; Peto T; Rakotosamimanana N; Grandjean Lapierre S; Iqbal Z Lancet Microbe; 2023 Feb; 4(2):e84-e92. PubMed ID: 36549315 [TBL] [Abstract][Full Text] [Related]
10. Assessing Nanopore Sequencing for Clinical Diagnostics: a Comparison of Next-Generation Sequencing (NGS) Methods for Mycobacterium tuberculosis. Smith C; Halse TA; Shea J; Modestil H; Fowler RC; Musser KA; Escuyer V; Lapierre P J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33055186 [TBL] [Abstract][Full Text] [Related]
12. Rapid Nanopore Sequencing of Plasmids and Resistance Gene Detection in Clinical Isolates. Lemon JK; Khil PP; Frank KM; Dekker JP J Clin Microbiol; 2017 Dec; 55(12):3530-3543. PubMed ID: 29021151 [TBL] [Abstract][Full Text] [Related]
13. Direct detection of drug-resistant Murphy SG; Smith C; Lapierre P; Shea J; Patel K; Halse TA; Dickinson M; Escuyer V; Rowlinson MC; Musser KA Front Public Health; 2023; 11():1206056. PubMed ID: 37457262 [No Abstract] [Full Text] [Related]
14. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Pankhurst LJ; Del Ojo Elias C; Votintseva AA; Walker TM; Cole K; Davies J; Fermont JM; Gascoyne-Binzi DM; Kohl TA; Kong C; Lemaitre N; Niemann S; Paul J; Rogers TR; Roycroft E; Smith EG; Supply P; Tang P; Wilcox MH; Wordsworth S; Wyllie D; Xu L; Crook DW; Lancet Respir Med; 2016 Jan; 4(1):49-58. PubMed ID: 26669893 [TBL] [Abstract][Full Text] [Related]
15. Rapid multiplex MinION nanopore sequencing workflow for Influenza A viruses. King J; Harder T; Beer M; Pohlmann A BMC Infect Dis; 2020 Sep; 20(1):648. PubMed ID: 32883215 [TBL] [Abstract][Full Text] [Related]
16. Primed and ready: nanopore metabarcoding can now recover highly accurate consensus barcodes that are generally indel-free. Chang JJM; Ip YCA; Neo WL; Mowe MAD; Jaafar Z; Huang D BMC Genomics; 2024 Sep; 25(1):842. PubMed ID: 39251911 [TBL] [Abstract][Full Text] [Related]
17. Proof of concept for multiplex amplicon sequencing for mutation identification using the MinION nanopore sequencer. Whitford W; Hawkins V; Moodley KS; Grant MJ; Lehnert K; Snell RG; Jacobsen JC Sci Rep; 2022 May; 12(1):8572. PubMed ID: 35595858 [TBL] [Abstract][Full Text] [Related]
18. Whole Genome Sequencing of Influenza A and B Viruses With the MinION Sequencer in the Clinical Setting: A Pilot Study. Imai K; Tamura K; Tanigaki T; Takizawa M; Nakayama E; Taniguchi T; Okamoto M; Nishiyama Y; Tarumoto N; Mitsutake K; Murakami T; Maesaki S; Maeda T Front Microbiol; 2018; 9():2748. PubMed ID: 30483243 [No Abstract] [Full Text] [Related]
19. Towards clinical molecular diagnosis of inherited cardiac conditions: a comparison of bench-top genome DNA sequencers. Li X; Buckton AJ; Wilkinson SL; John S; Walsh R; Novotny T; Valaskova I; Gupta M; Game L; Barton PJ; Cook SA; Ware JS PLoS One; 2013; 8(7):e67744. PubMed ID: 23861798 [TBL] [Abstract][Full Text] [Related]